Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study

Public Health Genomics

Volumn 13, Issue 1, 2009, Pages 1-12

  Ramsey, Scott ^a   Blough, David ^b   Mcdermott, Cara ^a   Clarke, Lauren ^d   Bennett, Robin ^c   Burke, Wylie ^b,c   Newcomb, Polly ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Cancer; Gene variant testing; Polymorphism; Quality of life; Screening behavior

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; DEMOGRAPHY; DIET; EXERCISE; FEMALE; GENETIC VARIABILITY; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

CANCER; GENE VARIANT TESTING; POLYMORPHISM; QUALITY OF LIFE; SCREENING BEHAVIOR;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MUTATION; NEOPLASM PROTEINS; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; WASHINGTON; YOUNG ADULT;

EID: 77149137122     PISSN: 16624246     EISSN: None     Source Type: Journal    
DOI: 10.1159/000206346     Document Type: Article

References (56)

1. American Cancer Society: Cancer Facts and Figures stet 2007. Available at: http://www. cancer.org/docroot/stt/content/stt-1x- Cancer-Facts-Figures- 2007.asp. Accessed December 17, 2007.
2. Ramsey SD, Yoon P, Moonesinghe R, et al: Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006; 8: 571-575. (Pubitemid 44402034)
3. Lichtenstein P, Holm NV, Verkasalo PK, et al: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85. (Pubitemid 30451850)
4. Houlston RS, Tomlinson IP: Polymorphisms and colorectal tumor risk. Gastroenterology 2001; 121: 282-301.
5. Hubner RA, Houlston RS: MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. Int J Cancer 2007; 120: 1027-1035. (Pubitemid 46214302)
6. Chen K, Jiang QT, He HQ: Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 2005; 11: 331-335. (Pubitemid 40125233)
7. Kaklamani VG, Hou N, Bian Y, et al: TGFBR1 6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol 2003; 21: 3236-3243. (Pubitemid 46606255)
8. Collins FS: Shattuck lecture - medical and societal consequences of the Human Genome Project. N Engl J Med 1999; 341: 28-37.
9. Collins CD, Purohit S, Podolsky RH, et al: The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Vascul Pharmacol 2006; 45: 258-267. (Pubitemid 44765288)
10. US Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005; 143: 355-361.
11. Lynch HT, Fusaro RM, Lynch JF: Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control. Future Oncol 2007; 3: 169-181. (Pubitemid 46592725)
12. Newcomb PA, Baron J, Cotterchio M, et al: Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 2331-2343. (Pubitemid 351196365)
13. Janz NK, Becker MH: The Health Belief Model: a decade later. Health Educ Q 1984; 11: 1-47.
14. Leventhal H, Diefenbach M, Leventhal E: Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cog Ther Res 1992; 16: 143-163.
15. Milne S, Sheeran P, Orbell S: Prediction and intervention in health-related behavior: a meta-analytic review of protection motivation theory. J Appl Soc Psychol 2000; 30: 106-143.
16. Audrain J, Schwartz MD, Lerman C, et al: Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1997; 19: 370-377. (Pubitemid 28363406)
17. Croyle RT, Lerman C: Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 1999;25: 59-66. (Pubitemid 29211771)
18. Schlich-Bakker KJ, ten Kroode HF, Ausems MG: A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 2006; 62: 13-20. (Pubitemid 43832070)
19. Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000; 8: 731-738.
20. Gooding HC, Organista K, Burack J, et al: Genetic susceptibility testing from a stress and coping perspective. Soc Sci Med 2006; 62: 1880-1890.
21. Marteau TM, Weinman J: Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 2006; 62: 1360-1368.
22. Decruyenaere M, Evers-Kiebooms G, Welkenhuysen M, et al: Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. Psychooncology 2000; 9: 528-536.
23. Gritz ER, Peterson SK, Vernon SW, et al: Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005; 23: 1902-1910.
24. Van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, et al: The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study. Psychooncology 2007; 16: 1121-1129.
25. Esplen MJ, Madlensky L, Aronson M, et al: Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 2007; 72: 394-401.
26. Van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, et al: Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ Couns 2007; 65: 58-68.
27. Ramsey SD, Berry K, Moinpour C, et al: Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 2002; 97: 1228-1234.
28. EuroQol Group: EQ-5D: An instrument to describe and value health. 2007. Available at: http://www.euroqol.org. Accessed November 7, 2008.
29. Palmer RC, Emmons KM, Fletcher RH, et al: Familial risk and colorectal cancer screening health beliefs and attitudes in an insured population. Prev Med 2007; 45: 336-341.
30. Coughlin SS, Berkowitz Z, Hawkins NA, et al: Breast and colorectal cancer screening and sources of cancer information among older women in the United States: results from the 2003 Health Information National Trends Survey. Prev Chronic Dis 2007; 4: A57.
31. Young WF, McGloin J, Zittleman L, et al: Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health 2007; 23: 238-245.
32. Kinney AY, Hicken B, Simonsen SE, et al: Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families. Am J Gastroenterol 2007; 102: 153-162.
33. Center on the Evaluation of Value and Risk in Health: The Cost-Effectiveness Analysis Registry. 2007. Available at: http://www. tufts-nemc.org/cearegistry. Accessed June 23, 2008.
34. Patrick DL, Erickson P: Health Status and Health Policy. New York, Oxford University Press, 1993.
35. Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1-30.
36. Murff HJ, Byrne D, Syngal S: Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 2004; 27: 239-245.
37. Sweet KM, Bradley TL, Westman JA: Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002; 20: 528-537.
38. Tyler CV Jr, Snyder CW: Cancer risk assessment: examining the family physician's role. J Am Board Fam Med 2006; 19: 468-477.
39. Centers for Disease Control and Prevention: Use of colorectal cancer tests - United States, 2002, 2004, and 2006. Morb Mortal Wkly Rep 2008; 57: 253-258.
40. Fletcher RH, Lobb R, Bauer MR, et al: Screening patients with a family history of colorectal cancer. J Gen Intern Med 2007; 22: 508-513.
41. Rees CE, Sheard CE, Echlin K: The relationship between the information-seeking behaviours and information needs of partners of men with prostate cancer: a pilot study. Patient Educ Couns 2003; 49: 257-261.
42. Beydoun HA, Beydoun MA: Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control 2008; 19: 339-359.
43. Sarfaty M, Wender R: How to increase colorectal cancer screening rates in practice. CA Cancer J Clin 2007; 57: 354-366.
44. Ferreira MR, Dolan NC, Fitzgibbon ML, et al: Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol 2005; 23: 1548-1554.
45. Harewood GC, Wiersema MJ, Melton LJ 3rd: A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186-3194.
46. Ramsey SD, Burke W, Pinsky L, et al: Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 2494-2500.
47. Marteau TM, Croyle RT: The new genetics. Psychological responses to genetic testing. BMJ 1998; 316: 693-696.
48. Esplen MJ, Madlensky L, Butler K, et al: Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 2001; 103: 9-15.
49. Meiser B, Halliday JL: What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002; 54: 1463-1470.
50. Claes E, Denayer L, Evers-Kiebooms G, et al: Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 2004; 55: 265-274.
51. Claes E, Evers-Kiebooms G, Denayer L, et al: Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure. J Genet Couns 2005; 14: 349-363.
52. US Census Bureau: Computer and Internet Use in the United States. 2005. Available at: http://www.census.gov/prod/2005pubs/ p23-208.pdf. Accessed June 23, 2008.
53. Persky S, Kaphingst KA, Condit CM, et al: Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review. Genet Med 2007; 9: 727-738.
54. Marteau TM, Lerman C: Genetic risk and behavioural change. BMJ 2001; 322: 1056-1059.
55. Aktan-Collan K, Haukkala A, Mecklin JP, et al: Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001; 93: 608-611. (Pubitemid 32701422)
56. Schwartz MD, Peshkin BN, Hughes C, et al: Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002; 20: 514-520.